Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

The role of antigen expression by thymomas in myasthenia gravis (MG) is not clear. Previous reports of acetylcholine receptor (AChR) mRNA expression by the highly sensitive reverse transcription-polymerase chain reactions (RT-PCR) produced varying results. To try to clarify this issue, we first used...

Detaylı Bibliyografya
Asıl Yazarlar:	Maclennan, C, Vincent, A, Marx, A, Willcox, N, Gilhus, N, Newsom-Davis, J, Beeson, D
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
Yazar:: Croxen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Antibodies to AChRs in seronegative myasthenia gravis
Yazar:: Leite, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
Yazar:: Farrugia, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
Yazar:: Bonifati, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Yazar:: Mygland, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations.
Yazar:: Croxen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Splice-site mutations in the achr epsilon subunit gene associated with congenital myasthenic syndrome
Yazar:: Croxen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Thymoma and paraneoplastic myasthenia gravis.
Yazar:: Marx, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands.
Yazar:: Faber, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Correlation between polymorphisms in the AChR gamma and delta subunit promoters and clinical phenotype in AChR deficiency patients
Yazar:: Bonifati, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Yazar:: Vuslat Yilmaz, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
Yazar:: Lee, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
Yazar:: Rui Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Yazar:: Buckley, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
Yazar:: Saxena, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.
Yazar:: Bonifati, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis
Yazar:: Yu Cai, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Yazar:: Deymeer, F, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
Yazar:: Pawan T Ojha, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
Yazar:: Gregory Kordas, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.
Yazar:: Gizem A Kaya, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
Yazar:: Antonino Lupica, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients.
Yazar:: PLOS ONE Staff
Baskı/Yayın Bilgisi: (2015-01-01)

Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
Yazar:: PLOS ONE Staff
Baskı/Yayın Bilgisi: (2015-01-01)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
Yazar:: Chao Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

A cysteine residue close to the C-terminus of the E subunit is essential for surface acetylcholine receptor (AChR) expression: Implications for AChR deficiency syndrome
Yazar:: Ealing, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Selective silencing of pathogenic a subunit AChR mutant in dominant disorders
Yazar:: Abdelgany, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
Yazar:: Li‐Kai Tsai, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times?
Yazar:: Megha Chetan Dhamne
Baskı/Yayın Bilgisi: (2023-01-01)

Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR.
Yazar:: Ealing, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Neuromyotonia and myasthenia gravis without thymoma.
Yazar:: Van Parijs, V, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit
Yazar:: Xin‐Ming Shen, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Ocular myasthenia gravis and thymoma
Yazar:: Victor Alegre-Ituarte, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
Yazar:: Plested, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain
Yazar:: Elena Cortés-Vicente, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
Yazar:: Nairong Xie, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
Yazar:: Webster, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients
Yazar:: Eleonora Lekova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
Yazar:: Yuping Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
Yazar:: Beeson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)